NCT04371276View on ClinicalTrials.gov

Seroepidemiology of Viral Hepatitis in Hong Kong

CompletedOBSERVATIONAL
Enrollment

2,888

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

May 31, 2022

Conditions
Viral Hepatitis
Interventions
OTHER

No intervention

Blood samples will be collected from recruited subjects from invited households for testing for hepatitis B (HBsAg, anti-HBs and anti-HBc) and hepatitis A (anti-HAV)

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04371276 - Seroepidemiology of Viral Hepatitis in Hong Kong | Biotech Hunter | Biotech Hunter